We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIRG icon
3751
Airgain
AIRG
$74.7M
$2.07K ﹤0.01%
343
AIXI
3752
Xiao-I
AIXI
$976K
$1.99K ﹤0.01%
18
-6
-25% -$1.26K
DOMA
3753
DELISTED
Doma Holdings, Inc.
DOMA
$1.97K ﹤0.01%
325
PHX
3754
DELISTED
PHX Minerals
PHX
$1.96K ﹤0.01%
600
MOLN
3755
Molecular Partners
MOLN
$156M
$1.92K ﹤0.01%
269
LU icon
3756
Lufax Holding
LU
$1.29B
$1.91K ﹤0.01%
805
SLAI
3757
DELISTED
SOLAI Ltd ADS
SLAI
$1.89K ﹤0.01%
103
-6
-6% -$112
BLCO icon
3758
Bausch + Lomb
BLCO
$5.84B
$1.89K ﹤0.01%
130
BPYPM
3759
Brookfield Property Partners 6.25% Class A Cumulative Redeemable Preferred Units Series 1
BPYPM
$1.83K ﹤0.01%
125
FTK icon
3760
Flotek Industries
FTK
$1.32B
$1.8K ﹤0.01%
367
+1
+0.3% +$4
SOND
3761
DELISTED
Sonder
SOND
$1.76K ﹤0.01%
381
APYX icon
3762
Apyx Medical
APYX
$175M
$1.72K ﹤0.01%
1,284
NEUP
3763
Neuphoria Therapeutics
NEUP
$21.1M
$1.68K ﹤0.01%
183
+74
+68% +$806
LEJU
3764
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$1.67K ﹤0.01%
6,410
+1,840
+40% +$2.16K
TECX
3765
Tectonic Therapeutic
TECX
$570M
$1.65K ﹤0.01%
100
-1
-1% -$16
UPLD icon
3766
Upland Software
UPLD
$12.6M
$1.62K ﹤0.01%
65
-8
-11% -$211
BODI icon
3767
The Beachbody Company
BODI
$72.3M
$1.58K ﹤0.01%
187
CTMX icon
3768
CytomX Therapeutics
CTMX
$734M
$1.57K ﹤0.01%
1,291
GP
3769
GreenPower Motor Co
GP
$10.5M
$1.55K ﹤0.01%
150
PDLI
3770
DELISTED
PDL BioPharma, Inc.
PDLI
$1.51K ﹤0.01%
612
OKUR
3771
OnKure Therapeutics
OKUR
$168M
$1.48K ﹤0.01%
98
-999
-91% -$16.9K
CIAN
3772
DELISTED
Cian PLC American Depositary Shares, each representing one Ordinary Share
CIAN
$1.46K ﹤0.01%
430
TV icon
3773
Televisa
TV
$1.5B
$1.46K ﹤0.01%
526
CRVS icon
3774
Corvus Pharmaceuticals
CRVS
$1.17B
$1.44K ﹤0.01%
791
CLSD
3775
DELISTED
Clearside Biomedical
CLSD
$1.42K ﹤0.01%
73

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.